These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1121845)

  • 21. [Characteristics of the reactions of patients with fibrous-cavernous pulmonary tuberculosis to anti-bacterial preparations].
    Butenko GE; Noreĭko BV
    Vrach Delo; 1971 Aug; 8():80-2. PubMed ID: 5143073
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pulmonary tuberculosis and megamycetoma: observations on 8 cases].
    Lo Schiavo L; Scarpazza G; Fici G; Avallone R
    G Ital Mal Torace; 1969; 23(6):299-300 passim. PubMed ID: 5403799
    [No Abstract]   [Full Text] [Related]  

  • 23. [Development of pulmonary tuberculosis under the influence of treatment with capreomycin. Clinical and biological considerations].
    Viallier MJ; Perrin LF; Cayré RM
    Lyon Med; 1966 Nov; 216(47):1169-72 passim. PubMed ID: 5988407
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical study on the therapy of pulmonary tuberculosis with Capreomycin].
    Saishin Igaku; 1966 Jan; 21(1):164-77. PubMed ID: 5965936
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical study on tuberactinomycin, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of agranulocytosis during ethoxyd therapy].
    Selavri TV; Shifrina RS
    Sov Med; 1974 Oct; (10):114-7. PubMed ID: 4428229
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study of tuberactinomycin-N in pulmonary tuberculosis (author's transl)].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1973 Oct; 48(10):473-9. PubMed ID: 4780239
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multiple allergy to antitubercular agents as a cause of unsuccessful treatment of pulmonary tuberculosis].
    Popović J; Praso R
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():101-4. PubMed ID: 4280599
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical use of capromycin in pulmonary tuberculosis].
    Zierski M; Bek E
    Gruzlica; 1969 Jul; 37(7):649-57. PubMed ID: 4900503
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemoblastic reaction in a patient with pulmonary tuberculosis developed after the use of tubazid and PAS].
    Samillo GK; Al'tshuler ML
    Vrach Delo; 1974 Sep; 0(9):77-8. PubMed ID: 4428720
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effectiveness of prolonged antibacterial therapy in newly detected patients with active pulmonary tuberculosis].
    Kuropatkin IF; Chuprova KP
    Probl Tuberk; 1967; 45(9):32-5. PubMed ID: 5606475
    [No Abstract]   [Full Text] [Related]  

  • 32. [Improved methods of treatment of pulmonary tuberculosis].
    Pregowski W; Madey J
    Gruzlica; 1973 Jul; 41(7):711-53. PubMed ID: 4730975
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radiological manifestations of the bactericidal activity of Rifampicin. (Early and transitory increase of exudative pulmonary opacity)].
    Gramazio V; Del Bono M; Zuccali G
    Arch Tisiol Mal Appar Respir; 1969 Jan; 24(1):46-56. PubMed ID: 5306185
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment with capreomycin, with special reference to toxic effects.
    Hesling CM
    Tubercle; 1969 Mar; 50():Suppl:39-41. PubMed ID: 5402544
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research on primary resistance to antitubercular agents and antibiotics in the antituberculosis centers].
    Santi GM; Poggiopollini M
    Minerva Med; 1967 Jun; 58(49):2285-8. PubMed ID: 6029301
    [No Abstract]   [Full Text] [Related]  

  • 36. [Secondary aldosteronism syndrome in the case of pulmonary tuberculosis therapy].
    Bromberg-Sznek S; Chodkowska S; Potworowska M
    Gruzlica; 1966 Aug; 34(8):757-63. PubMed ID: 5974776
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of hyposensitization in drug intolerance in patients with pulmonary tuberculosis].
    Spesivtsev OG; Prosvetov IuV; Gal'chanskaia LD
    Probl Tuberk; 1987; (12):30-3. PubMed ID: 3444822
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical picture and treatment of fibrocavernous tuberculosis of the lungs complicated by nonspecific infection].
    Ianovskaia LM; Murakhovskaia SG; Kaliuk LN
    Klin Med (Mosk); 1973 Mar; 51(3):76-9. PubMed ID: 4201985
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical studies on the ketogenic effect of certain antitubercular drugs in patients with diabetes and pulmonary tuberculosis].
    Onisk J
    Wiad Lek; 1968 May; 21(9):743-5. PubMed ID: 4875998
    [No Abstract]   [Full Text] [Related]  

  • 40. [2 cases of acute side effects in the use of antitubercular preparations].
    Tsereteli AN; Shcherbakov AI
    Probl Tuberk; 1968; 46(9):85-6. PubMed ID: 5718441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.